Previous studies demonstrated that the loss of STAT1 activation or expression was found in malignant cells derived from various tumors, while the loss of CD86 expression resulted in a decrease in tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma [30–35]. The gene discussed is CD86; the disease is diffuse large B-cell lymphoma.